**Core Concept**
Direct thrombin inhibitors (DTIs) are a class of anticoagulant medications that directly inhibit the activity of thrombin, a key enzyme in the coagulation cascade. By preventing thrombin from converting fibrinogen to fibrin, DTIs effectively prevent the formation of blood clots.

**Why the Correct Answer is Right**
Bivalirudin is a synthetic peptide that directly binds to and inhibits thrombin, preventing its activation of factors XI, X, and V, and the conversion of fibrinogen to fibrin. This mechanism of action makes bivalirudin a direct thrombin inhibitor, effective in preventing thrombus formation in various clinical settings, including acute coronary syndromes and peripheral artery disease.

**Why Each Wrong Option is Incorrect**
**Option A:** Heparin is an indirect thrombin inhibitor, which exerts its anticoagulant effects by activating antithrombin III, which in turn inhibits thrombin.
**Option B:** Fondaparinux is a synthetic pentasaccharide that inhibits factor Xa, but does not directly inhibit thrombin.
**Option C:** Argatroban is a small molecule that indirectly inhibits thrombin by binding to the thrombin active site, but is not a direct thrombin inhibitor like bivalirudin.

**Clinical Pearl / High-Yield Fact**
Bivalirudin is a useful alternative to heparin in patients with heparin-induced thrombocytopenia, a potentially life-threatening condition.

**Correct Answer: C. Argatroban is a small molecule that indirectly inhibits thrombin by binding to the thrombin active site, but is not a direct thrombin inhibitor like bivalirudin.